Additionally, this study did not take into considerationmedication usage due to the limitations of the NHANES database, including theexclusion of angiotensin receptor-neprilysin inhibitor (ARNI) and sodium-dependent glucose transporters 2 (SGLT2) inhibitors, which have been proven to decreasemortality across the entire spectrum of heart failure. Here, SLC5A2 is linked to heart failure.